1 / 9

Asthma Drugs Market in the US 2015-2019

Asthma Drugs Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Inquire for more information @ http://www.sandlerresearch.org/inquire-before-buying?rname=38192

paulnelson74
Download Presentation

Asthma Drugs Market in the US 2015-2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Published June-2015 No. of Pages 103 (Single User License of the Report is Available at US $3000) Asthma Drugs Market in the US 2015-2019 Reach us at Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org Visit: http://www.sandlerresearch.org

  2. The analysts forecast asthma drugs market in the US to grow at a CAGR of 4.64% over the period 2014-2019. According to the report, pharmaceutical companies are developing drugs that have a better safety and efficacy profile than those already available in the market. These drugs are undergoing clinical trials or are awaiting approval by regulatory agencies. For instance, NVA237 by Novartis and Mepolizumab by GlaxoSmithKline are among the most promising drugs for the treatment of asthma. Mepolizumab by GlaxoSmithKline was submitted for approval as a maintenance treatment for severe eosinophilic asthma to the US Food and Drug Administration (FDA) in November 2014. Tralokinumab by AstraZeneca is another promising molecule, which is under phase III clinical trials. Asthma Drugs Market in the US 2015-2019 CAGR Forecast Purchase a Copy at http://www.sandlerresearch.org/purchase?rname=38192

  3. This report covers the present scenario and the growth prospects of the asthma drugs market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sale of various classes of drugs used to treat asthma, which include: Bronchodilators, Leukotriene antagonists, Mast cell stabilizers, Immunosuppressants, Combination of LABA/ICS Asthma Drugs Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Asthma Drugs Market in the US 2015-2019 Report Covers Inquire Further on the Report at http://www.sandlerresearch.org/inquire-before-buying?rname=38192

  4. Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy. Asthma Drugs Market in the US 2015-2019 About Asthma Drugs Read Full Report at http://www.sandlerresearch.org/asthma-drugs-market-in-the-us-2015-2019.html

  5. Market Driver Rise in disease prevalence • Market Challenge Unknown disease etiology • Market Trend Popularity of combination therapies Asthma Drugs Market in the US 2015-2019 Market Key Components Discount on the Report at http://www.sandlerresearch.org/discount?rname=38192

  6. AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline and Merck Asthma Drugs Market in the US 2015-2019 Key Vendors Other Prominent Vendors Abbott Laboratories AddexTherapeutics Alkermes AstraZeneca AurobindoPharma AvanirPharmaceuticals Cerecor Chugai Pharmaceutical Dart NeuroScience Dr. Reddy’s Laboratories Edgemont Pharmaceuticals E-Therapeutics Euthymics Evotec F. Hoffmann-La Roche Fabre Kramer GedeonRichter H. Lundbeck Intra-Cellular Therapies Janssen Pharmaceuticals Lupin LuyePharma MSI MethylationSciences Naurex Neuralstem Novartis Order By Fax: http://www.sandlerresearch.org/order-by-fax?rname=38192

  7. Asthma Drugs Market in the US 2015-2019 Key Regions Browse Other Reports on Pharmaceutical Market

  8. What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Asthma Drugs Market in the US 2015-2019 Key Questions Answered in this Report Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org

  9. About US: Sandlerresearch.org (http://www.sandlerresearch.org/ ) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business. Mail US at: sales@sandlerresearch.org Phone: + 1 888 391 5441 Find US:

More Related